Epa and Vitamins drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Epa (epa (eicosapentaenoic acid)) and Vitamins (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include maternal exposure before pregnancy among females and foetal growth restriction among males.

The phase IV clinical study analyzes what interactions people have when they take Epa and Vitamins. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Epa?

Epa has active ingredients of epa (eicosapentaenoic acid). It is often used in high blood cholesterol. eHealthMe is studying from 623 Epa users. Check the latest studies of Epa.

What is Vitamins?

Vitamins has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 122,456 Vitamins users. Check the latest studies of Vitamins.



On Jul, 12, 2026

16 people who take Epa and Vitamins together, and have interactions are studied.

Epa and Vitamins drug interactions.

What are the common drug interactions of Epa and Vitamins, by gender? *:

female:

  1. Maternal exposure before pregnancy (use of substance before pregnancy)
  2. Premature delivery
  3. Pregnancy
  4. Inflammation
  5. Maternal exposure during pregnancy (use of substance during pregnancy)
  6. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  7. Prolonged labour
  8. Urticaria (rash of round, red welts on the skin that itch intensely)
  9. Appendicitis (inflammation of the appendix)
  10. Gallbladder disorder

male:

  1. Foetal growth restriction (poor growth of a baby while in the mother's womb during pregnancy)
  2. Low birth weight baby
  3. Maternal exposure before pregnancy (use of substance before pregnancy)
  4. Premature baby
  5. Small for dates baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age)
  6. Drug ineffective
  7. Pain

What are the common drug interactions of Epa and Vitamins, by age (0-1 to 60+)? *:

0-1:

  1. Foetal growth restriction (poor growth of a baby while in the mother's womb during pregnancy)
  2. Low birth weight baby
  3. Maternal exposure before pregnancy (use of substance before pregnancy)
  4. Premature baby
  5. Small for dates baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age)

2-9:

n/a

10-19:

n/a

20-29:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Appendicitis (inflammation of the appendix)
  3. Gallbladder disorder
  4. Maternal exposure before pregnancy (use of substance before pregnancy)
  5. Premature delivery
  6. Pregnancy
  7. Maternal exposure during pregnancy (use of substance during pregnancy)
  8. Prolonged labour

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Inflammation
  2. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 12 people, 75.00%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 43.75%
  3. Sleep Disorder: 6 people, 37.50%
  4. Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 6 people, 37.50%
  5. Nausea And Vomiting: 6 people, 37.50%
  6. Indigestion: 6 people, 37.50%
  7. Hypersensitivity: 6 people, 37.50%
  8. Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 6 people, 37.50%
  9. Foetal Growth Restriction (poor growth of a baby while in the mother's womb during pregnancy): 6 people, 37.50%
  10. Depression: 6 people, 37.50%

* Approximation only. Some reports may have incomplete information.

Do you take Epa and Vitamins?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Epa and Vitamins:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Epa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vitamins:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Epa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vitamins and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on epa (eicosapentaenoic acid) and ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Epa and Vitamins, respectively), and Epa and Vitamins (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: